Trickle may have blown it by selling CRL. They are currently at the price I sold 'em, and they've raised guidance after hours. So Friday should be a nice day for CRL. Sigh.
>>WILMINGTON, Mass., June 14 (Reuters) - Charles River Laboratories International Inc. (NYSE:CRL - news), which provides rats and mice for drug research, on Thursday raised its earnings estimates, citing stronger-than-expected income from its drug discovery product lines.
The Wilmington, Massachussets-based company said it now projects fully diluted second-quarter earnings of 21 to 22 cents per share compared to the company's previous forecast of earnings of 18 to 20 cents per share.
The company said it expects full-year earnings per share to be in the range of 75 to 78 cents per share vs. earlier guidance of 72 to 76 cents.
Analysts polled by research firm Thomson Financial/First Call expect Charles River to post earnings of 19 to 20 cents per share in the second quarter, and earnings of 74 to 75 cents a share for the year ending December 2001.
Charles River shares closed down 4.3 percent, or $1.30, at $28.70 on the New York Stock Exchange.<<
snip
Cheers, Tuck |
